Neurovalens successfully secured 510(k) clearance from the FDA on October 27, 2023 for its Modius Sleep device with relation to treatment of insomnia and/or anxiety. The clearance was.
A randomized trial suggests that combining education together with a focus on the emotional side of diabetes has the greatest impact on diabetes distress. Such interventions also cut costs.